RYAN ANDERSON: Open Payments
NPI 1407847833 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 27 payments from 11 companies in 2025. Trend: 2023 $655 · 2024 $743 · 2025 $501
Food & beverage: $501
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $99 |
| Lilly USA, LLC | 5 | $90 |
| Abbott Laboratories | 2 | $47 |
| Phathom Pharmaceuticals, Inc. | 4 | $47 |
| Novo Nordisk Inc | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| HARMONY BIOSCIENCES LLC | 2 | $39 |
| Celltrion USA Inc. | 2 | $39 |
| Intercept Pharmaceuticals, Inc. | 1 | $20 |
| JAZZ PHARMACEUTICALS INC. | 1 | $19 |
Products named: XIFAXAN, MOUNJARO, VOQUEZNA, OFEV, WAKIX, VEGZELMA, ETERNA, OCALIVA.
Industry payments across WV — which companies pay providers there.
